Beta-adrenergic blockade in ponies with recurrent obstructive pulmonary disease

Area of Science:

• Veterinary Medicine
• Respiratory Physiology
• Pharmacology

Background:

• Recurrent airway obstruction (RAO) in ponies is characterized by airway hyperresponsiveness during exacerbations.
• The role of the beta-adrenergic system in RAO pathophysiology remains unclear.

Purpose of the Study:

• To investigate the effect of beta-adrenergic blockade using propranolol on airway responsiveness in ponies with RAO.
• To determine if the beta-adrenergic system influences airway hyperresponsiveness or airway caliber during remission and exacerbation phases of RAO.

Main Methods:

• Six ponies with RAO and six controls received aerosol histamine challenges before and after propranolol administration.
• Measurements included airway responsiveness, dynamic compliance (Cdyn), and pulmonary resistance (RL).
• Studies were conducted during clinical remission (Period A) and acute airway obstruction (Period B).

Main Results:

• Propranolol did not alter airway responsiveness, Cdyn, or RL in either group during remission (Period A).
• In RAO ponies during acute obstruction (Period B), propranolol significantly increased RL but did not affect Cdyn or airway responsiveness.
• Control ponies showed no significant changes after propranolol administration in Period B.

Conclusions:

• The beta-adrenergic system plays a role in regulating central airway caliber in RAO ponies during acute exacerbations.
• Beta-adrenergic blockade does not appear to be involved in the mechanism of histamine-induced airway hyperresponsiveness in RAO ponies.